nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
β3 adrenergic receptor in the kidney may be a new player in sympathetic regulation of renal function
|
Procino, Giuseppe |
|
2016 |
90 |
3 |
p. 555-567 13 p. |
artikel |
2 |
β3-Adrenoreceptors in the thick ascending limb of Henle and in principal cells of the collecting duct work to concentrate urine
|
Bichet, Daniel G. |
|
2016 |
90 |
3 |
p. 471-473 3 p. |
artikel |
3 |
An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
|
Ludwig-Portugall, Isis |
|
2016 |
90 |
3 |
p. 525-539 15 p. |
artikel |
4 |
An unusual case of acute kidney injury after colonoscopy
|
Hashimoto, Nobuhiro |
|
2016 |
90 |
3 |
p. 711- 1 p. |
artikel |
5 |
A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis
|
Anders, Hans-Joachim |
|
2016 |
90 |
3 |
p. 493-501 9 p. |
artikel |
6 |
Arterioenteric fistula 12 years after kidney transplant
|
Takahashi, Kazuhiro |
|
2016 |
90 |
3 |
p. 710- 1 p. |
artikel |
7 |
CAPing inflammation and acute kidney injury
|
Inoue, Tsuyoshi |
|
2016 |
90 |
3 |
p. 462-465 4 p. |
artikel |
8 |
Cardiac dysfunction in Pkd1-deficient mice with phenotype rescue by galectin-3 knockout
|
Balbo, Bruno E. |
|
2016 |
90 |
3 |
p. 580-597 18 p. |
artikel |
9 |
Checkmate: kidney injury associated with targeted cancer immunotherapy
|
Perazella, Mark A. |
|
2016 |
90 |
3 |
p. 474-476 3 p. |
artikel |
10 |
Clinical, biopsy, and mass spectrometry characteristics of renal apolipoprotein A-IV amyloidosis
|
Dasari, Surendra |
|
2016 |
90 |
3 |
p. 658-664 7 p. |
artikel |
11 |
Clinical trials of intensive versus less intensive control of hypertension: HOPE or HYPE?
|
Wyatt, Christina M. |
|
2016 |
90 |
3 |
p. 460-462 3 p. |
artikel |
12 |
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitors
|
Cortazar, Frank B. |
|
2016 |
90 |
3 |
p. 638-647 10 p. |
artikel |
13 |
C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E
|
Lai, Weiyan |
|
2016 |
90 |
3 |
p. 610-626 17 p. |
artikel |
14 |
Cytosolic HDAC6 is accumulated in cystic kidneys
|
Li, Xin |
|
2016 |
90 |
3 |
p. 705- 1 p. |
artikel |
15 |
Development of a microphysiological model of human kidney proximal tubule function
|
Weber, Elijah J. |
|
2016 |
90 |
3 |
p. 627-637 11 p. |
artikel |
16 |
Editorial Board
|
|
|
2016 |
90 |
3 |
p. A7- 1 p. |
artikel |
17 |
Expanding the spectrum of systemic amyloid diseases: a new hint from the kidney
|
Obici, Laura |
|
2016 |
90 |
3 |
p. 479-481 3 p. |
artikel |
18 |
Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function
|
Dhayat, Nasser A. |
|
2016 |
90 |
3 |
p. 648-657 10 p. |
artikel |
19 |
Gastrointestinal potassium binding–more than just lowering serum [K+]: patiromer, potassium balance, and the renin angiotensin aldosterone axis
|
Emmett, Michael |
|
2016 |
90 |
3 |
p. 484-486 3 p. |
artikel |
20 |
Greenbaum LA, Fila M, Ardissino G, et al. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome. Kidney Int. 2016;89:701–711
|
|
|
2016 |
90 |
3 |
p. 709- 1 p. |
artikel |
21 |
Hypoxia-inducible factor-1 plays a role in phosphate-induced vascular smooth muscle cell calcification
|
Mokas, Sophie |
|
2016 |
90 |
3 |
p. 598-609 12 p. |
artikel |
22 |
Inhibition of NLRP3 inflammasome as a therapeutic intervention in crystal-induced nephropathy
|
Sakai, Norihiko |
|
2016 |
90 |
3 |
p. 466-468 3 p. |
artikel |
23 |
Insights into the epidemiology and management of lupus nephritis from the US rheumatologist's perspective
|
Hoover, Paul J. |
|
2016 |
90 |
3 |
p. 487-492 6 p. |
artikel |
24 |
Insulin and the phosphatidylinositol 3-kinase signaling pathway regulate Ribonuclease 7 expression in the human urinary tract
|
Eichler, Tad E. |
|
2016 |
90 |
3 |
p. 568-579 12 p. |
artikel |
25 |
In this Issue
|
|
|
2016 |
90 |
3 |
p. 457- 1 p. |
artikel |
26 |
Journal club
|
|
|
2016 |
90 |
3 |
p. 458-459 2 p. |
artikel |
27 |
Limited health literacy in advanced kidney disease
|
Taylor, Dominic M. |
|
2016 |
90 |
3 |
p. 685-695 11 p. |
artikel |
28 |
Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway
|
Hallan, Stein I. |
|
2016 |
90 |
3 |
p. 665-673 9 p. |
artikel |
29 |
More detail is needed for updating clinical guidelines
|
Martínez García, L. |
|
2016 |
90 |
3 |
p. 707-708 2 p. |
artikel |
30 |
Multiphasic effects of blood pressure on survival in hemodialysis patients
|
Hannedouche, Thierry |
|
2016 |
90 |
3 |
p. 674-684 11 p. |
artikel |
31 |
Never make assumptions: the complicated role of complement in urinary tract infections
|
Thurman, Joshua M. |
|
2016 |
90 |
3 |
p. 469-471 3 p. |
artikel |
32 |
Pavkov ME, Weil EJ, Fufaa GD, et al. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int. 2016;89:226–234
|
|
|
2016 |
90 |
3 |
p. 709- 1 p. |
artikel |
33 |
Preventing peritoneal membrane fibrosis in peritoneal dialysis patients
|
Zhou, Qin |
|
2016 |
90 |
3 |
p. 515-524 10 p. |
artikel |
34 |
Regulatory T cells in kidney disease and transplantation
|
Hu, Min |
|
2016 |
90 |
3 |
p. 502-514 13 p. |
artikel |
35 |
Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System
|
Jhaveri, Kenar D. |
|
2016 |
90 |
3 |
p. 706-707 2 p. |
artikel |
36 |
Subscription Information Page
|
|
|
2016 |
90 |
3 |
p. A8- 1 p. |
artikel |
37 |
Table of Contents
|
|
|
2016 |
90 |
3 |
p. A9-A12 nvt p. |
artikel |
38 |
The Authors Reply
|
Uhlig, Katrin |
|
2016 |
90 |
3 |
p. 708- 1 p. |
artikel |
39 |
The Case | Acute renal failure and refractory hyponatremia
|
Denis, C. |
|
2016 |
90 |
3 |
p. 713-714 2 p. |
artikel |
40 |
The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis
|
Choudhry, Naheed |
|
2016 |
90 |
3 |
p. 540-554 15 p. |
artikel |
41 |
The rise of FGF23: should insights from population-based studies inform future clinical trials?
|
Wetmore, James B. |
|
2016 |
90 |
3 |
p. 477-479 3 p. |
artikel |
42 |
Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors
|
Weir, Matthew R. |
|
2016 |
90 |
3 |
p. 696-704 9 p. |
artikel |
43 |
Worldwide growing epidemic of CKD: fact or fiction?
|
De Nicola, Luca |
|
2016 |
90 |
3 |
p. 482-484 3 p. |
artikel |